Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endometrial ablation for refractory postmenopausal bleeding with continuous hormone replacement therapy

L B Spaulding1

  • 1Department of Obstetrics and Gynecology, St. Joseph Hospital, Denver, Colorado.

Fertility and Sterility
|December 1, 1994
PubMed
Summary

Continuous hormone replacement therapy (HRT) effectively manages menopausal bleeding for many women. For persistent cases, adjusting progestin dosage or endometrial ablation can resolve refractory bleeding caused by uterine pathology.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Delivery through the maternal bladder during trial of labor.

Obstetrics and gynecology·1992
Same author

Current concepts of management of rupture of the gravid uterus.

Obstetrics and gynecology·1979
Same author

The role of ultrasonography in the management of endometritis/salpingitis/peritonitis.

Obstetrics and gynecology·1979
Same author

Pneumoperitoneum after hysterectomy.

JAMA·1979
Same author

Cytotoxicity of cardiac principles.

Journal of medicinal chemistry·1965

Area of Science:

  • Gynecology
  • Reproductive Medicine
  • Menopause Management

Background:

  • Refractory bleeding is a common concern for menopausal women using hormone replacement therapy (HRT).
  • Identifying underlying benign uterine pathology is crucial for effective treatment.

Purpose of the Study:

  • To evaluate the efficacy of endometrial ablation and identify benign uterine pathology in menopausal women with refractory bleeding despite continuous HRT.
  • To determine the role of escalating progestin dosage in managing persistent bleeding.

Main Methods:

  • A prospective study involving 171 menopausal women treated with continuous HRT.
  • An algorithm of endometrial biopsy, hormone manipulation, hysteroscopy, and endometrial resection-ablation for refractory bleeding was employed.

Related Experiment Videos

Main Results:

  • 65.4% of women achieved amenorrhea with initial continuous HRT.
  • Increasing progestin dosage resolved bleeding in 87% of remaining cases.
  • Endometrial resection-ablation successfully treated refractory bleeding in 13% of patients, revealing polyps, leiomyomas, and adenomyosis in 85.7%.

Conclusions:

  • Initial continuous HRT is effective for many menopausal women with bleeding.
  • Doubling progestin dosage is effective for most remaining cases.
  • Endometrial resection-ablation is a successful treatment for refractory bleeding caused by benign uterine pathology.